Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Vertex Pharmaceuticals Incorporated (VRTX) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Vertex Pharmaceuticals Incorporated (VRTX) - free report >>
Image: Bigstock
New Strong Buy Stocks for April 27th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Kaleyra, Inc. : This company that provides mobile communication services has seen the Zacks Consensus Estimate for its current year earnings increasing 18.2% over the last 60 days.
Kaleyra, Inc. Price and Consensus
Kaleyra Inc price-consensus-chart | Kaleyra Inc. Quote
Black Diamond Therapeutics, Inc. (BDTX - Free Report) : This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.
Black Diamond Therapeutics, Inc. Price and Consensus
Black Diamond Therapeutics, Inc. price-consensus-chart | Black Diamond Therapeutics, Inc. Quote
Vertex Pharmaceuticals Incorporated (VRTX - Free Report) : This company that engages in developing and commercializing therapies for the treatment of cystic fibrosis has seen the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.
Vertex Pharmaceuticals Incorporated Price and Consensus
Vertex Pharmaceuticals Incorporated price-consensus-chart | Vertex Pharmaceuticals Incorporated Quote
Cabaletta Bio, Inc. (CABA - Free Report) : This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 13.4% over the last 60 days.
Cabaletta Bio, Inc. Price and Consensus
Cabaletta Bio, Inc. price-consensus-chart | Cabaletta Bio, Inc. Quote
Ra Medical Systems, Inc. : This commercial-stage medical device company has seen the Zacks Consensus Estimate for its current year earnings increasing 65% over the last 60 days.
Ra Medical Systems, Inc. Price and Consensus
Ra Medical Systems, Inc. price-consensus-chart | Ra Medical Systems, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.1% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>